Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease.

PLoS One. 2012;7(5):e37564. Epub 2012 May 25.

Gandhi S, Vaarmann A, Yao Z, Duchen MR, Wood NW, Abramov AY.

Source

Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.

Abstract

BACKGROUND:

Parkinson's disease is a common neurodegenerative disease characterised by progressive loss of dopaminergic neurons, leading to dopamine depletion in the striatum. Mutations in the PINK1 gene cause an autosomal recessive form of Parkinson's disease. Loss of PINK1 function causes mitochondrial dysfunction, increased reactive oxygen species production and calcium dysregulation, which increases susceptibility to neuronal death in Parkinson's disease. The basis of neuronal vulnerability to dopamine in Parkinson's disease is not well understood.

METHODOLOGY:

We investigated the mechanism of dopamine induced cell death in transgenic PINK1 knockout mouse neurons. We show that dopamine results in mitochondrial depolarisation caused by mitochondrial permeability transition pore (mPTP) opening. Dopamine-induced mPTP opening is dependent on a complex of reactive oxygen species production and calcium signalling. Dopamine-induced mPTP opening, and dopamine-induced cell death, could be prevented by inhibition of reactive oxygen species production, by provision of respiratory chain substrates, and by alteration in calcium signalling.

CONCLUSIONS:

These data demonstrate the mechanism of dopamine toxicity in PINK1 deficient neurons, and suggest potential therapeutic strategies for neuroprotection in Parkinson's disease.


The full-text of this paper is available at the link below
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037564